Diaceutics, a Parsippany, N.J.-based diagnostic commercialization company, raised $5m in new mezzanine financing.
Backers included WhiteRock Capital Partners and Silicon Valley Bank.
The company will use the funds to invest in the data analytics services, continue to expand its laboratory network, and grow its team.
Led by Peter Keeling, CEO, Diaceutics provides pharmaceutical companies with solutions to accelerate their market penetration by getting access to insights generated from real-time testing data from its worldwide laboratory network.
Thirty-one out of the world’s top pharmaceutical companies are clients.